Literature DB >> 33284416

Association between rs662 (A > G) and rs854560 (A > T) polymorphisms in PON1 gene and the susceptibility for psoriasis in mestizo population of Western Mexico.

A A Hernández-Collazo1, Oscar Pérez-Méndez2,3, Victoria López-Olmos2, V Delgado-Rizo4, J F Muñoz-Valle5, Erika Martínez-López6, D G Villanueva-Quintero7, Carolina Domínguez-Díaz8, Mary Fafutis-Morris8, Anabell Alvarado-Navarro9.   

Abstract

Psoriasis is a chronic, autoimmune skin disease. In psoriasis, PON1 activity is diminished and peroxidation biomarkers are elevated. The most studied PON1 polymorphisms are rs662 (A > G) and rs854560 (A > T), which have been associated with the antioxidant activity of PON1, risk of cardiovascular diseases and psoriasis development. The aim of this study, was to determine the association of rs662 (A > G) and rs854560 (A > T) PON1 polymorphisms with psoriasis susceptibility in Western Mexico population. In this case-control study, we included 104 psoriasis patients and 124 control subjects. The genotyping of polymorphisms rs662 (A > G) and rs854560 (A > T) of PON1 was carried out by PCR-RFLPs. The lipid profiles were quantified by enzymatic colorimetric method, and PON1 activity was determined by spectrophotometry. The lipid profile levels, except HDL-C and atherogenic index, were higher in patients vs. controls. Patients presented lower paraoxonase and arylesterase activity. The G allele of rs662 (A > G) is associated with risk for psoriasis, while the T allele of rs854560 (A > T) is associated with low susceptibility to psoriasis. The AG haplotype was more frequent within the patient group (p < 0.05). The AA and AG genotypes of rs662 (A > G) and TT and AA genotypes of rs854560 (A > T) are associated with lower PONase and ARE activity in patients vs. controls. Patients with the G allele of rs662 (G > A) and T alleles of rs854560 (A > T) show significant differences in the lipid levels in comparison to controls. These results suggest that carriers of G allele of rs662 (A > G) present a greater susceptibility to psoriasis.

Entities:  

Keywords:  Arylesterase; HDL-C; PON1; Paraoxonase; Polymorphisms; Psoriasis

Mesh:

Substances:

Year:  2020        PMID: 33284416     DOI: 10.1007/s11033-020-06031-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  41 in total

Review 1.  Autoimmune diseases.

Authors:  A Davidson; B Diamond
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

2.  Psoriasis and risk of cardiovascular disease: a meta-analysis of cohort studies.

Authors:  Wan-Jie Gu; Cui-Lian Weng; Yun-Tao Zhao; Qing-Hua Liu; Rui-Xing Yin
Journal:  Int J Cardiol       Date:  2013-08-07       Impact factor: 4.164

3.  Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation.

Authors:  H Jakubowski
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

4.  Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis.

Authors:  Gulden Baskol; Huseyin Demir; Mevlut Baskol; Eser Kilic; Filiz Ates; Derya Kocer; Sabahattin Muhtaroglu
Journal:  Clin Biochem       Date:  2005-10       Impact factor: 3.281

5.  Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus.

Authors:  M I Mackness; D Harty; D Bhatnagar; P H Winocour; S Arrol; M Ishola; P N Durrington
Journal:  Atherosclerosis       Date:  1991-02       Impact factor: 5.162

6.  Psoriasis is associated with lipid abnormalities at the onset of skin disease.

Authors:  Lotus Mallbris; Fredrik Granath; Anders Hamsten; Mona Ståhle
Journal:  J Am Acad Dermatol       Date:  2006-01-19       Impact factor: 11.527

Review 7.  Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta-analysis.

Authors:  I M Miller; T Skaaby; C Ellervik; G B E Jemec
Journal:  Br J Dermatol       Date:  2013-12       Impact factor: 9.302

8.  Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

Authors:  M I Mackness; S Arrol; C Abbott; P N Durrington
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

9.  Serum lipid profile paraoxonase and arylesterase activities in psoriasis.

Authors:  Aysun Toker; Melek Kadi; A Kadir Yildirim; Hulya Aksoy; Fatih Akçay
Journal:  Cell Biochem Funct       Date:  2009-04       Impact factor: 3.685

10.  Validation of PON1 enzyme activity assays for longitudinal studies.

Authors:  Karen Huen; Rebecca Richter; Clement Furlong; Brenda Eskenazi; Nina Holland
Journal:  Clin Chim Acta       Date:  2008-12-24       Impact factor: 3.786

View more
  3 in total

1.  Data Mining and Meta-Analysis of Psoriasis Based on Association Rules.

Authors:  Jiarui Ou; Jianglin Zhang
Journal:  J Healthc Eng       Date:  2022-01-27       Impact factor: 2.682

Review 2.  The Involvement of Oxidative Stress in Psoriasis: A Systematic Review.

Authors:  Elena-Codruța Dobrică; Matei-Alexandru Cozma; Mihnea-Alexandru Găman; Vlad-Mihai Voiculescu; Amelia Maria Găman
Journal:  Antioxidants (Basel)       Date:  2022-01-29

Review 3.  Psoriasis between Autoimmunity and Oxidative Stress: Changes Induced by Different Therapeutic Approaches.

Authors:  Marija V Medovic; Vladimir Lj Jakovljevic; Vladimir I Zivkovic; Nevena S Jeremic; Jovana N Jeremic; Sergey B Bolevich; Ana B Ravic Nikolic; Vesna M Milicic; Ivan M Srejovic
Journal:  Oxid Med Cell Longev       Date:  2022-03-12       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.